Professor in Pediatrics, Northwestern University Medical School
Pediatric Infectious Disease
Dr. Ram Yogev, MD
Doctor Ram Yogev, MD practices Pediatric Infectious Disease. He graduated from The Hebrew University of Jerusalem Hadassah Medical School. He received 2 awards: "Regional Top Doctor" and "Fellow (FAAP)". Yogev is also published. He has 84 publications published. The lastest publication: "Antiretroviral Therapy for Nevirapine-Exposed Children With HIV Infection.'
Publications
- Antiretroviral Therapy for Nevirapine-Exposed Children With HIV Infection.
- Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012.
- Early viral suppression improves neurocognitive outcomes in HIV-infected children.
- Clinical characteristics and genotypes of rotavirus in adults.
- Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants.
- Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents.
- Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy.
- Long-term highly suppressed HIV-infected children and adolescents with negative rapid HIV tests due to significant antibody loss.
- Addressing and improving the continuum of care for HIV-affected children: challenges and solutions.
- Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.
- Indirect protection of adults from rotavirus by pediatric rotavirus vaccination.
- Dynamics of the resting CD4+ T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age.
- Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children.
- Pediatric oncology: "an area of great change".
- Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
- Higher incidence of perineal community acquired MRSA infections among toddlers.
- In Utero and Postnatal Exposure to Antiretrovirals Among HIV-Exposed But Uninfected Children in the United States.
- Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children.
- Meningococcal disease: the advances and challenges of meningococcal disease prevention.
- Correlation of HIV-specific immunity, viral control, and diversification following planned multiple exposures to autologous HIV in a pediatric population.
- Neuroschistosomiasis due to Schistosoma haematobium presenting as spinal cord tumor.
- Steady-state pharmacokinetics of tenofovir-based regimens in HIV-infected pediatric patients.
- Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy.
- Safety and pharmacokinetics of a single 1500-mg dose of famciclovir in adolescents with recurrent herpes labialis.
- Differential gene expression of soluble CD8+ T-cell mediated suppression of HIV replication in three older children.
- Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis.
- A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulatio...
- Respiratory syncytial virus, antibiotics, and the critical care dilemma.
- Pharmacokinetics and distribution of linezolid in cerebrospinal fluid in children and adolescents.
- To treat or not to treat is the nagging question.
- The 2009 COID recommendations for RSV prophylaxis: issues of efficacy, cost, and evidence-based medicine.
- B-type natriuretic peptide and heart failure in patients with ventricular septal defect: a pilot study.
- Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy.
- Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in human immunodeficiency virus-infected pediatric patients.
- Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneu...
- Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents.
- Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
- Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infecte...
- Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia.
- Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatri...
- Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia.
- Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 month...
- Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results.
- Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AI...
- Virologic response to potent antiretroviral therapy and modeling of HIV dynamics in early pediatric infection.
- Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).
- Opportunities to prevent HIV transmission in newborns.
- A behavioral and cognitive profile of clinically stable HIV-infected children.
- Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
- Influenza vaccine confusion: a call for an alternative evidence-based approach.
- Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical...
- Ritonavir-based highly active antiretroviral therapy in human immunodeficiency virus type 1-infected infants younger than 24 months of age.
- A rational approach to the management of ventricular shunt infections.
- Bacterial meningitis in children: critical review of current concepts.
- Balancing the upside and downside of antiretroviral therapy in children.
- Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children.
- The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
- A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy.
- Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children.
- Single-dose safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, in HIV-infected children.
- Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
- Pharmacokinetics of antiretrovirals administered to HIV-infected children via gastrostomy tube.
- Rapid human immunodeficiency virus decay in highly active antiretroviral therapy (HAART)-experienced children after starting mega-HAART.
- Pneumococcal endocarditis in children.
- Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection.
- Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugat...
- Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.
- Streptococcus pneumoniae infections in the neonate.
- Linezolid for the treatment of complicated skin and skin structure infections in children.
- Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
- Neonatal sepsis caused by Streptococcus bovis variant (biotype II/2): report of a case and review.
- Mycobacterium gordonae bacteremia in an asymptomatic adolescent with acquired immunodeficiency syndrome.
- Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients.
- Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children.
- The role of protease inhibitor therapy in children with HIV infection.
- Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae.
- Invasive pneumococcal infections in children with asplenia.
- Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy.
- Six year multicenter surveillance of invasive pneumococcal infections in children.
- Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection.
- Quantification of human immunodeficiency virus type 1 proviral DNA by using TaqMan technology.
- Is noma neonatorum a presentation of ecthyma gangrenosum in the newborn?
- Recombinant glycoprotein vaccines for human immunodeficiency virus-infected children and their effects on viral quasispecies.
Schools
Hadassah Medical School The Hebrew University Of Jerusalem
Hadassah
Children39s Memorial Hospital
Doctors Specialties
- Pediatrics
- Pediatric Infectious Disease
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FAAP)
Education
-
McGaw Medical Center of Northwestern University -
The Hebrew University of Jerusalem Hadassah Medical School
Hospital
-
Lurie Children's Hospital of Chicago -
Northwestern Memorial Hospital -
Ann & Robert H. Lurie Children?
Helpful Reviews
Similar Doctors
|
Dr. Peter W. McCauley Sr., MD |
|
|
Dr. Yessenia Castro-Caballero, MD |
|
|
Dr. Jenny H. Kim, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Molly M. Diaz, MD |
|
|
Dr. Jannine C. Joyce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristina L. Svenson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina L. Grant, MD |
|
|
Dr. Seema Nair, MD |
|
|
Dr. Andrew J. Kreppel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth M. Boyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Latania K. Logan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tina Q. Tan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen C. Hayani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ben Z. Katz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary K. Prahl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Ritika M. Coelho, MB BS
This Doctor is OpenDoctor Recommended.
|